Psychiatric Symptoms in Oncological Patients at Nuclear Medicine Department


  • Huri Tilla İlce Department of Nuclear Medicine, Faculty of Medicine, Sakarya University, Sakarya, Turkey
  • Sezen Elhan Vargol Department of Nuclear Medicine, Faculty of Medicine Training and Research Hospital, Sakarya University, Sakarya, Turkey
  • Hatice Halis Department of Radiation Oncology, Faculty of Medicine Training and Research Hospital, Sakarya University, Sakarya, Turkey
  • Esra Yazici Department of Psychiatry, Faculty of Medicine, Sakarya University, Sakarya, Turkey



Depression, Anxiety, Fluoro-2-deoxy-d-glucose positron emission tomography-computed tomography, Oncology


Objective: In the process of PET/CT scanning, patients go through a general evaluation while their medical history is being taken, but it is often overlooked that these patients should be evaluated not only biologically but also bio psychosocially. Psychiatric symptom profiles and help-seeking behaviours of cancer patients were examined in this study.

Methods: Cancer patients presented to nuclear medicine clinic filled out sociodemographic data form, psychiatric admission evaluation form, Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI) and Symptom Checklist-90 (SCL-90) form for psychiatric symptom screening.

Results: In this study 27.8% of the patients had a Beck Depression score ≥18 and were in the risk group for depression, 31.7% of the patients experienced moderate or severe anxiety symptoms. Beck Depression Total and Beck Anxiety Total values were found significantly higher in women than in men. Only 10,2% of the cancer patients reported that they sought psychiatric help in the last 6 months. Among the patients who were risky for depression according to BDI only 25%  had been receiving psychiatric help and in among the patients who were risky for anxiety according to BAI only %26.9 had been receiving psychiatric help

Conclusion: Nuclear Medicine physicians' interest in psychiatric symptoms and help-seeking behaviors of cancer patients referred to Nuclear Medicine Clinics is very important in terms of psycho-oncology.


Download data is not yet available.


Metrics Loading ...

Plum Analytics Artifact Widget Block


Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160-74. PMid:18355377 PMid:21251875 DOI:

Smith H. Depression in cancer patients: Pathogenesis, implications and treatment (review). Oncol Lett. 2015;9(4):1509-14. PMid:25788991 DOI:

Uchitomi YF, Sugihara J. Aliason Program Influences Psychiatric Consultation Rates in Cancer Patients at a Japanese General Hospital. Seventh Annual Meeting of the European Society of Psychosocial Oncology Abstract; 1993. p. 99.

Hirschfeld RM. The comorbidity of major depression and anxiety disorders: recognition and management in primary care. Prim Care Companion J Clin Psychiatry 2001;3(6):244-54. PMid:15014592 DOI:

Mols F, Husson O, Roukema JA, van de Poll-Franse LV. Depressive symptoms are a risk factor for all-cause mortality: Results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry. J Cancer Surviv 2013;7:484-92. PMid:23677523 DOI:

Chan CM, Wan Ahmad WA, Yusof MM, Ho GF, Krupat E. Effects of depression and anxiety on mortality in a mixed cancer group: A longitudinal approach using standardised diagnostic interviews. Psychooncology. 2015;24(6):718-25. PMid:25345781 DOI:

Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: Version 2.0. Eur J Nuclear Med Mol Imaging. 2015;42(2):328-54. PMid:25452219 DOI:

Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consulting Clin Psychol. 1988;56(6):893-7. PMid:3204199 DOI:

Sahin NH, Durak A. The scale of coping styles with stress: its adaptation for university students. Turk J Psyc. 1995;10(34):56-73.

Ulusoy M, Sahin NH, Erkmen H. Turkish version of the beck anxiety inventory: psychometric properties. J Cogn Psychother. 1988;12:2.

Areias M, Kumar R, Barros H, Figueiredo E. Comparative incidence of depression in women and men, during pregnancy and after childbirth: Validation of the Edinburgh postnatal depression scale in Portuguese mothers. Br J Psychiatry. 1996;169(1):30-5. PMid:8818365 DOI:

Beck AT, Ward C, Mendelson M, Mock J, Erbaugh J. Beck depression inventory (BDI). Arch Gen Psychiatry. 1961;4(6):561-71. PMid:13688369 DOI:

Hisli N. Beck depresyon envanterinin universite ogrencileri icin gecerliligi, guvenilirligi. (A reliability and validity study of Beck Depression Inventory in a university student sample). J Psychol. 1989;7:3-13.

Derogatis L. SCL-90: Administration, Scoring and Procedures Manual I for the Revised Version. Baltimore: Johns Hopkins University School of Medicine; 1977.

Dağ İ. Belirti Tarama Listesi (Scl-90-R)’nin Üniversite Öğrencileri için güvenirliği ve geçerliği. Türk Psikiyatri Derg. 1991;2(1):5-12. DOI:

Saxena S, Thornicroft G, Knapp M, Whiteford H. Resources for mental health: Scarcity, inequity, and inefficiency. Lancet. 2007;370(9590):878-89. DOI:

Švec J, Švec P, Bencová V, Krčméry V. Anxio-depressive syndrome biopsychosocial model of supportive care. Klin onkol. 2015;28(3):177-82. PMid:26062619 DOI:

Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC Cancer. 2019;19(1):943. PMid:31604468 DOI:

Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet. 2007;370(9590):841-50. DOI:

Walker J, Hansen CH, Martin P, Symeonides S, Ramessur R, Murray G, et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: A cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry. 2014;1(5):343-50. PMid:26360998 DOI:

Chen Y, Ahmad M. Effectiveness of adjunct psychotherapy for cancer treatment: A review. Future Oncol. 2018;14(15):1487-96. PMid:29767550 DOI:

Caruso R, Nanni MG, Riba MB, Sabato S, Grassi L. The burden of psychosocial morbidity related to cancer: patient and family issues. Int Rev Psychiatry (Abingdon, England). 2017;29(5):389-402. PMid:28753076 DOI:

Bursalioglu FS, Aydin N, Yazici E, Yazici AB. The correlation between psychiatric disorders and women’s lives. J Clin Diagn Res. 2013;7(4):695-9. PMid:23730649 DOI:

Di Giacomo D, Cannita K, Ranieri J, Cocciolone V, Passafiume D, Ficorella C. Breast cancer and psychological resilience among young women. J Psychopathol. 2016;3(1):9001-5. DOI:

Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Anxiety and depression in patients with lung cancer before and after diagnosis: Findings from a population in Glasgow, Scotland. J Epidemiol Community Health. 1998;52(3):203-4. PMid:9616429 DOI:

Vodermaier A, Linden W, MacKenzie R, Greig D, Marshall C. Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br J Cancer. 2011;105(12):1814-7. PMid:22095232 DOI:

Simon A, Thompson M, Flashman K, Wardle J. Disease stage and psychosocial outcomes in colorectal cancer. Colorectal Dis. 2009;11(1):19-25. PMid:18355377 DOI:




How to Cite

İlce HT, Vargol SE, Halis H, Yazici E. Psychiatric Symptoms in Oncological Patients at Nuclear Medicine Department. Open Access Maced J Med Sci [Internet]. 2022 Mar. 21 [cited 2023 Mar. 28];10(A):734-9. Available from:



Nuclear Medicine